De-risk market access.
Accelerate portfolio revenue.
You back the innovation.
We build the scalable business.
We build GTM strategies that hospital buyers and payers actually say yes to.
We partner with HealthTech and MedTech investors to de-risk market access and turn clinical assets into scalable commercial engines.
We help your portfolio bypass institutional friction, accelerate time-to-revenue, and protect capital runway.
How we create value for your portfolio
Entering and scaling in complex healthcare systems is notorious for slow adoption, institutional friction, and wasted capital. If your portfolio companies are hitting procurement gridlock, their scaling will stall.
We transform reactive go-to-market efforts into focused, system-aligned execution that defends your fund's returns:
Accelerated market access
We break through healthcare system friction by aligning portfolio products directly with health system priorities and defining clear adoption pathways.
Capital-efficient commercialisation
We turn innovations into fundable businesses by designing health-specific business models and go-to-market plans and scaling revenue without the immediate overhead of full-time senior hires.
We identify and activate new revenue streams, assess international markets for strategic fit, and align product portfolios to real-world clinical demand.
Targeted revenue expansion
Value creation at every stage of the deal cycle
Early-stage / Post-seed
Go-to-Market & traction
How we move the needle:
We design scalable, health-specific business models and craft value propositions that land with clinical decision-makers, turning early innovation into measurable commercial traction.
Pre-deal / seed
Valuation & diligence
How we move the needle:
We conduct rigorous market viability assessments and build fundable, investor-ready business cases so you can validate product-market fit before committing capital.
Growth / Series A+
Expansion & scaling
How we move the needle:
We identify new B2B/B2G revenue streams, align product portfolios to sustained clinical demand, and prioritise international market entry for high-margin expansion.
Exits & restructuring
Commercial optimisation
How we move the needle:
We lead post-merger integration (PMI) for commercial directorates, optimising sales capabilities and aligning organisational structures to maximise enterprise value at exit.
We map our commercial expertise directly to your portfolio's maturity, ensuring capital is deployed efficiently from term sheet to exit.
How funds deploy us
Whether you are vetting a new asset or rescuing a stalled Series A investment, we integrate seamlessly into your deal flow.
Commercial Due Diligence
Don't rely solely on the founder's projections.
We conduct rigorous market viability assessments and validate market access pathways before you sign a term sheet, ensuring you back fundable, investor-ready business cases.
Fractional commercial leadership
We provide embedded interim CSO-level support.
We inject senior commercial direction to aggressively execute the GTM strategy and hit your revenue milestones, without the overhead of a full-time executive hire.
Fund advisory retainers
Ongoing strategic support and insider health system expertise for your deal team and portfolio leadership to sustain delivery momentum.
Why investors partner with us
What sets Buoyancy Health Strategy apart is our ability to combine commercial strategy with deep health system insider knowledge:
Over 15 years of sector expertise
Proven track record as a business strategist and consulting professional across MedTech, HealthTech, and pharma.
Buyer-side leadership experience
Direct executive leadership positions within NHS acute hospital providers and Integrated Care Boards (ICBs /payer organisations). We know how healthcare buyers evaluate risk, allocate budget, and adopt innovation.
Delivered projects across twelve countries in Europe, the Middle East, and Southeast Asia, bringing an international perspective to market expansion.
Global execution
Our track record of scalable growth
2x revenue growth and NHS adoption
Assisted a medical device start-up in re-engineering their go-to-market strategy, directly securing NHS adoption, scaling operations, and doubling revenue within 18 months.
5-year global capital allocation strategy
Conducted a global market analysis for a leading diagnostics company to identify high-margin expansion opportunities and focus investment priorities for a 5-year growth horizon.
Commercial post-merger integration
Led the post-merger integration for the commercial directorate of a national healthcare organisation, aligning roles, capabilities, and the structural shape of the directorate.
Let's explore what this could look like for your portfolio
Whether you need a commercial reality check on a target company or a GTM turnaround for an existing asset, let's connect.
Buoyancy Health Strategy
Steady. Strategic. Scalable Healthcare Growth
© 2025 Buoyancy Health Strategy Ltd. All rights reserved.